help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 68, No. 2 426-430
doi:10.1210/jcem-68-2-426
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LOCHE, S.
Right arrow Articles by PINTOR, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LOCHE, S.
Right arrow Articles by PINTOR, C.

Augmentation of Growth Hormone Secretion in Children With Constitutional Growth Delay by Short Term Clonidine Administration: A Pulse Amplitude-Modulated Phenomenon*

SANDRO LOCHE, ROSA PUGGIONI, TIZIANA FANNI, SILVANO G. CELLA, EUGENIO E. MÜLLER and CARLO PINTOR

Department of Pediatrics, Chair of Pediatric Endocrinology, University of Cagliari Cagliari, Italy
the Department of Pharmacology, University of Milan (S.G.C., E.E.M.) Milan, Italy

Address all correspondence and requests for reprints to: Prof. Carlo Pintor, Cattedra di Endocrinologia Pediatrica, Ospedale Microcitemico, Via Jenner, 09100 Cagliari, Italy.

We evaluated the effect of chronic clonidine administration on 24-h integrated GH secretion (IC-GH) in eight children (six boys and two girls; age, 6.0–13.0 yr) with constitutional growth delay (CGD). Clonidine was given orally in a daily dose of 0.1 mg/m2 at bedtime for 6 months; 24-h secretion studies were performed before and after 2 months of treatment. Clonidine caused a significant augmentation (P < 0.02) of mean IC-GH from 2.6 ± 0.4 (±SE) to 4.6 ± 0.6 µg/L. The increase in IC-GH was mainly the result of increased GH pulse amplitude, which rose from 12.3 ± 1.3 to 18.2 ± 2.1 µg/L (P < 0.01). The mean GH pulse amplitude was significantly higher (P < 0.02) during sleep (15.9 ± 2.4 µg/L) than during the awake hours (8.4 ± 1.5 µg/L) before treatment. During clonidine treatment the mean GH pulse amplitude during the awake hours (15.0 ± 3.8 µg/L) was similar to that during sleep (20.3 ± 3.1 µg/L). GH pulse frequency was not altered by treatment during either the awake or sleep hours. The mean insulin-like growth factor I levels after 2 (1400 ± 300 U/L) and 6 (1760 ± 430 U/L) months of treatment were significantly higher (P < 0.02 and P < 0.05, respectively) than the pretreatment value (920 ± 240 U/L). After 2 months of clonidine treatment, growth velocity increased from 3.1 ± 0.5 to 10.2 ± 1.0 cm/yr (P < 0.001), and after 6 months of treatment is was still significantly higher (7.0 ± 0.7 cm/yr; P < 0.02) than that before treatment. These results confirm the ability of clonidine to accelerate growth in children with CGD and indicate that clonidine is capable of increasing IC-GH levels. They also reinforce the view that many children with CGD have decreased endogenous GH secretion

* Presented in part at the 69th Annual Meeting of The Endocrine Society, Indianapolis, IN, June 10–12, 1987.

Received December 14, 1987.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society